Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy-Reference-Cited by-同舟云学术

Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy

Published:2021-04 Issue:7 Volume:14 Page:739-750
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Pereira Naveen L.,Rihal Charanjit,Lennon Ryan,Marcus Gil,Shrivastava Sanskriti,Bell Malcolm R.,So Derek,Geller Nancy,Goodman Shaun G.,Hasan Ahmed,Lerman Amir,Rosenberg Yves,Bailey Kent,Murad M. Hassan,Farkouh Michael E.

Funder

National Institutes of Health

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Cardiovascular pharmacogenomics and individualized drug therapy;Pereira;Nat Rev Cardiol,2009

2. Clopidogrel pharmacogenetics;Pereira;Circ Cardiovasc Interv,2019

3. ACCF/AHA clopidogrel clinical alert: approaches to the FDA “boxed warning;Holmes;J Am Coll Cardiol,2010

4. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

5. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach;International Journal of Cardiology;2024-11

2. Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications;Interventional Cardiology Clinics;2024-10

3. Evaluation of pharmacogenetic automated clinical decision support for clopidogrel;Pharmacogenomics;2024-09-11

4. Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital;Journal of Thrombosis and Thrombolysis;2024-09-06

5. Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis;Drugs;2024-09-05